Cargando…
Comparison of Three Chemotherapy Regimens in Elderly Patients with Diffuse Large B Cell Lymphoma: Experience at a Single National Reference Center in Mexico
Background. Although chemotherapy added to rituximab is a standard of care for diffuse large B cell lymphoma (DLBCL), treatment of patients ≥65 years of age remains controversial due to comorbidities. Methods. This is a retrospective, comparative, nonrandomized study of patients ≥65 years of age, wh...
Autores principales: | Nolasco-Medina, Diana, Reynoso-Noveron, Nancy, Mohar-Betancourt, Alejandro, Aviles-Salas, Alejandro, García-Perez, Osvaldo, Candelaria, Myrna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4958419/ https://www.ncbi.nlm.nih.gov/pubmed/27478844 http://dx.doi.org/10.1155/2016/9817606 |
Ejemplares similares
-
Cancer Trends in Mexico: Essential Data for the Creation and Follow-Up of Public Policies
por: Mohar-Betancourt, Alejandro, et al.
Publicado: (2017) -
ctDNA Is Useful to Detect Mutations at Codon 641 of Exon 16 of EZH2, a Biomarker for Relapse in Patients with Diffuse Large B-Cell Lymphoma
por: Díaz-Chávez, José, et al.
Publicado: (2022) -
Clinical and Epidemiological Profile of Breast Cancer in Mexico: Results of the Seguro Popular
por: Reynoso-Noverón, Nancy, et al.
Publicado: (2017) -
Rituximab in combination with cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in diffuse large B-cell lymphoma
por: Candelaria, Myrna, et al.
Publicado: (2021) -
Cancer Prevention Behaviors in Workers of a Referral Cancer Center in
Mexico City: A Pilot Study on Early Detection Awareness for
Cancer
por: Reynoso-Noverón, Nancy, et al.
Publicado: (2022)